» Articles » PMID: 28840050

Gastric Medullary Carcinoma with Sporadic Mismatch Repair Deficiency and a R273C Mutation: An Unusual Case with Wild-Type

Overview
Journal Case Rep Pathol
Publisher Wiley
Specialty Pathology
Date 2017 Aug 26
PMID 28840050
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Medullary carcinoma has long been recognized as a subtype of colorectal cancer associated with microsatellite instability and Lynch syndrome. Gastric medullary carcinoma is a very rare neoplasm. We report a 67-year-old male who presented with a solitary gastric mass. Total gastrectomy revealed a well-demarcated, poorly differentiated carcinoma with an organoid growth pattern, pushing borders, and abundant peritumoral lymphocytic response. The prior cytology was cellular with immunohistochemical panel consistent with upper gastrointestinal/pancreaticobiliary origin. Overall, the histopathologic findings were consistent with gastric medullary carcinoma. A mismatch repair panel revealed a mismatch repair protein deficient tumor with loss of MLH1 and PMS2 expression. BRAF V600E immunostain (VE1) and molecular testing were negative, indicating a wild-type gene. Tumor sequencing of demonstrated a wild-type gene, while our molecular panel identified c.817C>T (p.R273C) mutation. These findings were compatible with a sporadic tumor. Given that morphologically identical medullary tumors often occur in Lynch syndrome, it is possible that mismatch repair loss is an early event in sporadic tumors with p53 mutation being a late event. Despite having wild-type , this tumor is sporadic and unrelated to Lynch syndrome. This case report demonstrates that coordinate ancillary studies are needed to resolve sporadic versus hereditary rare tumors.

Citing Articles

Prognostic analysis of mutated genes and insight into effects of DNA damage and repair on mutational strand asymmetries in gastric cancer.

Shen Y, Shi K, Li D, Wang Q, Wu K, Feng C Biochem Biophys Rep. 2024; 37:101597.

PMID: 38371526 PMC: 10873876. DOI: 10.1016/j.bbrep.2023.101597.


Applications of human organoids in the personalized treatment for digestive diseases.

Wang Q, Guo F, Jin Y, Ma Y Signal Transduct Target Ther. 2022; 7(1):336.

PMID: 36167824 PMC: 9513303. DOI: 10.1038/s41392-022-01194-6.

References
1.
Aslan F, Yukruk F, Bugdayci Basal F, Durnali A . Gastric Medullary Carcinoma: A Rare Case Report. Case Rep Oncol Med. 2016; 2016:2875471. PMC: 4987474. DOI: 10.1155/2016/2875471. View

2.
Minamoto T, Mai M, Watanabe K, Ooi A, Kitamura T, Takahashi Y . Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor. Cancer. 1990; 66(5):945-52. DOI: 10.1002/1097-0142(19900901)66:5<945::aid-cncr2820660523>3.0.co;2-x. View

3.
Dogan M, Savas B, Utkan G, Bayar S, Ensari A, Icli F . A rare gastric neoplasm: gastric medullary carcinoma. Med Oncol. 2010; 28(4):945-7. DOI: 10.1007/s12032-010-9557-5. View

4.
Chetty R . Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol. 2012; 65(12):1062-5. DOI: 10.1136/jclinpath-2012-201067. View

5.
Hirai H, Yoshizawa T, Morohashi S, Haga T, Wu Y, Ota R . Clinicopathological significance of gastric poorly differentiated medullary carcinoma. Biomed Res. 2016; 37(2):77-84. DOI: 10.2220/biomedres.37.77. View